8 Results

People

  1. Makker
    Makker
  2. Coakley
    Coakley
  3. D'Angelo
    D'Angelo
  4. Healey
    Healey
  5. Motzer
    Motzer
  6. Panicek
    Panicek
  7. Tap
    Tap
  8. Ugolini
    Ugolini

Groups

  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (6)
  3. GDMT, Medicine (3)
  4. Gynecologic Medicine Service (3)
  5. Gynecology Disease Management Team (3)
  6. Sarcoma Service (2)
  7. Body Imaging Service (1)
  8. Genitourinary Oncology Service (1)
  9. Hematologic Malignancies, Division of (1)
  10. Nursing (1)
  1. "adverse reactions"
Formats
  1. Journal Article (8)
Groups
  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (6)
  3. GDMT, Medicine (3)
  4. Gynecologic Medicine Service (3)
  5. Gynecology Disease Management Team (3)
  6. Sarcoma Service (2)

More Groups

People
  1. Vicky Makker (3)
  2. David Panicek (1)
  3. Fergus Coakley (1)
  4. Heather Ugolini (1)
  5. John Healey (1)
  6. Robert Motzer (1)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2021 (2)
  4. 2019 (1)
  5. 1997 (1)
  6. 1991 (1)
Publications
  1. The Oncologist (4)
  2. American Journal of Roentgenology (1)
  3. Clinical Journal of Oncology Nursing (1)
  4. Clinical Review for General Practice (1)
  5. Immunology and Allergy Clinics of North America (1)
Publishers
  1. Oxford University Press (4)
  2. American Roentgen Ray Society (1)
  3. Elsevier Inc. (1)
  4. MEDIAFORMAT (1)
  5. Oncology Nursing Society (ONS) (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization and management of adverse reactions in patients with advanced endometrial cancer receiving lenvatinib plus pembrolizumab
    Journal Article

    Colombo, N.; Lorusso, D.; Monk, B. J.; Slomovitz, B.; Hasegawa, K.; Nogueira-Rodrigues, A.; Zale, M.; Okpara, C. E.; Barresi, G.; McKenzie, J.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Характеристика и управление нежелательными реакциями у пациентов с распространенным раком эндометрия, которые получают комбинацию ленватиниб плюс пембролизумаб
    Journal Article

    Colombo, N.; Lorusso, D.; Monk, B. J.; Slomovitz, B.; Hasegawa, K.; Nogueira-Rodrigues, A.; Zale, M.; Okpara, C. E.; Barresi, G.; McKenzie, J.; more...
    Clinical Review for General Practice (2023)

    Fulltext@MSK | Save
  • Characterization and management of adverse reactions from the clear study in advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab
    Journal Article

    Motzer, R.; George, S.; Merchan, J. R.; Hutson, T. E.; Song, X.; Perini, R. F.; Xie, R.; Bapat, U.; Puente, J.
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Characterization and management of adverse reactions in patients with advanced endometrial carcinoma treated with lenvatinib plus pembrolizumab
    Journal Article

    Makker, V.; Taylor, M. H.; Oaknin, A.; Casado Herraez, A.; Orlowski, R.; Dutta, L.; Ren, M.; Zale, M.; O'Malley, D. M.
    The Oncologist (2021)

    Fulltext@MSK | Save
  • Pexidartinib long-term hepatic safety profile in patients with tenosynovial giant cell tumors
    Journal Article

    Lewis, J. H.; Gelderblom, H.; van de Sande, M.; Stacchiotti, S.; Healey, J. H.; Tap, W. D.; Wagner, A. J.; Pousa, A. L.; Druta, M.; Lin, C. C.; more...
    The Oncologist (2021)

    Fulltext@MSK | Save
  • Avelumab immunotherapy: Management of adverse events associated with new treatment for Merkel cell carcinoma
    Journal Article

    Ugolini, H.; Bryan, J.; Hennessy, M.; Kaufman, H. L.; D'Angelo, S. P.
    Clinical Journal of Oncology Nursing (2019)

    Fulltext@MSK | Save
  • Iodine allergy: An oyster without a pearl?
    Journal Article

    Coakley, F. V.; Panicek, D. M.
    American Journal of Roentgenology (1997)

    Fulltext@MSK | Save
  • Allergy to Beta-Lactam Antibiotics
    Journal Article

    Shepherd, G. M.
    Immunology and Allergy Clinics of North America (1991)

    Fulltext@MSK | Save